NVIDIA
NVDA
Tesla
TSLA
Super Micro Computer
SMCI
4
Palantir
PLTR
5
Hims & Hers Health
HIMS
US Stock MarketDetailed Quotes
APGE Apogee Therapeutics
- 33.060
- -0.310-0.93%
Close Feb 25 16:00 ET
- 37.990
- +4.930+14.91%
Pre 04:02 ET
1.93BMarket Cap-12.82P/E (TTM)
33.855High31.900Low745.13KVolume33.750Open33.370Pre Close24.54MTurnover1.89%Turnover RatioLossP/E (Static)58.51MShares72.29052wk High2.63P/B1.31BFloat Cap31.90052wk Low--Dividend TTM39.49MShs Float72.290Historical High--Div YieldTTM5.86%Amplitude14.190Historical Low32.940Avg Price1Lot Size
Apogee Therapeutics News
Apogee Therapeutics | 8-K: Apogee Therapeutics Provides Pipeline Progress and Reports Third Quarter 2024 Financial Results
Apogee Therapeutics | 10-Q: Q3 2024 Earnings Report
Apogee Therapeutics | 10-Q: Q2 2024 Earnings Report
Apogee Therapeutics | 8-K: Apogee Therapeutics Provides Pipeline Progress and Reports Second Quarter 2024 Financial Results
Apogee Therapeutics | 10-Q: Q1 2024 Earnings Report
Apogee Therapeutics | 8-K: Apogee Therapeutics Highlights Pipeline Progress and Reports First Quarter 2024 Financial Results
Apogee Therapeutics | 10-K: FY2023 Annual Report
Apogee Therapeutics | 8-K: Apogee Therapeutics Provides Pipeline Progress and Reports Fourth Quarter and Full Year 2023 Financial Results
Apogee Therapeutics | 10-Q: Quarterly report
Apogee Therapeutics | 8-K: Apogee Highlights Corporate Progress and Reports Third Quarter 2023 Financial Results
Apogee Therapeutics | 10-Q: Quarterly report
Apogee Therapeutics | 8-K: Apogee Highlights Corporate Progress and Reports Second Quarter 2023 Financial Results
No More